Neuroimmunological Mechanisms of Xiao-Yao-San Against Chronic Stress-Induced Colorectal Cancer: A Bioinformatics and Single-Cell Sequencing Study [0.03%]
小雅散抗慢性压力诱导的结直肠癌的神经免疫机制研究：生物信息学与单细胞测序联合分析
Ying Li,Shengya Yang,Haoran Li et al.
Ying Li et al.
Objective: This study aimed to integrate bioinformatics, network pharmacology, and single-cell sequencing to explore the potential neuro-immune mechanisms by which the traditional Chinese medicine formula Xiao-Yao-San (XY...
Erratum: Ginseng-Derived Exosomes Attenuate Immune Evasion in NSCLC via PD-L1 Modulation [Corrigendum] [0.03%]
人参源外泌体通过调节PD-L1抑制NSCLC免疫逃逸[勘误]
[This corrects the article DOI: 10.2147/CMAR.S540462.]. © 2026 Zhu et al.
Published Erratum
Cancer management and research. 2026 Mar 2:18:590886. DOI:10.2147/CMAR.S590886 2026
Dual Role of AITD in TgAb-Positive PTC: Delayed Antibody Clearance with Enhanced RAIT Response [0.03%]
自身免疫性甲状腺疾病在TgAb阳性PTC中的双重作用：延迟的抗体清除和增强的放射性碘治疗反应
Hua Ge,Shuting Chen,Linlin Song et al.
Hua Ge et al.
Background and objective: Elevated thyroglobulin antibody (TgAb) levels in postoperative management of papillary thyroid carcinoma (PTC) are often attributed to tumor recurrence, while the potential impact of autoimmune t...
Identifying of Ubiquitin-Fold Modifier 1 as a Potential Prognostic Biomarker for Unresectable Pancreatic Cancer by Proteomics Analysis [0.03%]
基于蛋白质组学分析鉴定泛素折叠修饰蛋白1作为不可切除性胰腺癌预后生物标志物的可能性
Juan Wang,Kun Xu,Longjin Xu et al.
Juan Wang et al.
Background: The prognosis for unresectable pancreatic cancer remains poor, with limited biomarkers available to predict treatment response and survival. This study aimed to identify novel protein biomarkers associated wit...
Hypertriglyceridemia During Anticancer Therapy in Pediatric Patients with Acute Lymphoblastic Leukemia - A Nationwide Experience [0.03%]
儿童急性淋巴细胞白血病抗肿瘤治疗过程中发生高甘油三酯血症的全国调查经历
Joanna Zawitkowska,Eryk Latoch,Katarzyna Karska et al.
Joanna Zawitkowska et al.
Purpose: In this study, we aimed to assess the demographics and incidence of hypertriglyceridemia (HTG) during acute lymphoblastic leukemia (ALL) treatment, complications related to HTG, and the treatment strategies appli...
Clinicopathological and Genomic Analysis of SMARCA4-Deficient Non-Small Cell Lung Cancer: A Retrospective Cohort Study [0.03%]
SMARCA4缺陷型非小细胞肺癌的临床病理及基因组分析：一项回顾性队列研究
Dongmei Chen,Heng Zhang,Diming Wang et al.
Dongmei Chen et al.
Background: SMARCA4-deficient non-small cell lung cancer (SMARCA4-dNSCLC) is a rare, aggressive subtype with limited treatment options. This study analyzed clinical, pathological, molecular, and prognostic features to imp...
Pre-Treatment HBV Activation Modulates Circulating Immune Markers in Hepatocellular Carcinoma Patients Undergoing TACE Plus ICIs and Anti-VEGF Antibodies/TKIs [0.03%]
TACE联合ICIs和抗VEGF抗体/TKIs治疗的肝细胞癌患者术前HBV激活对循环免疫标志物的影响
Lihao Qin,Linzhou Zhu,Yu Wang et al.
Lihao Qin et al.
Objective: To evaluate the impact of pre-treatment hepatitis B virus (HBV) activation on peripheral immune status and treatment response in unresectable hepatocellular carcinoma (uHCC) patients undergoing transarterial ch...
A Multiphase CT-Based Radiomics-Clinical Model to Identify Inadequate Future Liver Remnant Hypertrophy After Portal Vein Embolization Before Major Hepatectomy [0.03%]
基于多相CT的影像组学-临床模型预测门静脉栓塞前的大肝切除术后未来残余肝脏 hypertrophy不足
Rui Zhou,Dong Liu,Jian Huang et al.
Rui Zhou et al.
Purpose: To develop and internally validate a multiphase contrast-enhanced computed tomography (CT) based radiomics-clinical nomogram for pre-operative prediction of inadequate future liver remnant (FLR) hypertrophy after...
CAR-T Cell Therapy in Glioblastoma: Overcoming Immunological Barriers and Advancing Clinical Translation [0.03%]
CAR-T细胞治疗在胶质母细胞瘤中的应用：克服免疫屏障和推动临床转化
Parvin Pourmasoumi,Ali Pourmasoumi,Farshid Zamani et al.
Parvin Pourmasoumi et al.
Chimeric antigen receptor (CAR) T-cell therapy has delivered unprecedented clinical benefit in hematological malignancies, yet its successful translation to solid tumors remains a major unmet clinical challenge. Glioblastoma (GBM), the most...
A Pharmacogenomic Basis for Tolerance of 5-Fluorouracil Following Early, Severe Toxicity from Capecitabine in a CDA Ultrarapid Metabolizer Colon Cancer Patient: A Case Report [0.03%]
卡泊芬净早期严重毒性后氟尿苷耐药性的药物基因组学基础：一例CDA超快代谢结直肠癌患者的报告
Tinashe Adrian Mazhindu,Zedias Chikwambi,Edith Matsikidze et al.
Tinashe Adrian Mazhindu et al.
Introduction: Capecitabine is an oral prodrug that is converted to 5-FU via three enzyme-catalysed steps: carboxylesterase (CES), cytidine deaminase (CDA), and thymidine phosphorylase (TYMS). Approximately 80-90% of 5-FU,...